Gene · 2813
Papers2,809
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 2,809
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| An exploration of barriers and facilitators to implementing a nonalcoholic fatty liver disease pathway for people with type 2 diabetes in primary care. | Diabet Med | 2022 | 35100462 | PubTator, text mining | PubMed |
| Adenovirus-based vaccines-a platform for pandemic preparedness against emerging viral pathogens. | Mol Ther | 2022 | 35092844 | PubTator, text mining | PubMed |
| Lassa virus glycoprotein complex review: insights into its unique fusion machinery. | Biosci Rep | 2022 | 35088070 | PubTator, text mining | PubMed |
| General Practitioners' Attitudes Toward Artificial Intelligence-Enabled Systems: Interview Study. | J Med Internet Res | 2022 | 35084342 | PubTator, text mining | PubMed |
Tumor Susceptibility Gene 101 (TSG101) Contributes to Virion Formation of Porcine Reproductive and Respiratory Syndrome Virus via Interaction with the Nucleocapsid (N) Protein along with the Early Secretory Pathway. | J Virol | 2022 | 35080428 | PubTator, text mining | PubMed |
| Findings and lessons learnt implementing a cardiovascular disease quality improvement program in Australian primary care: a mixed method evaluation. | BMC Health Serv Res | 2022 | 35078460 | PubTator, text mining | PubMed |
| Structure of the Core Postfusion Porcine Endogenous Retrovirus Fusion Protein. | mBio | 2022 | 35073741 | PubTator, text mining | PubMed |
| Severe Lenke 1 and 2 adolescent idiopathic scoliosis had poorer perioperative outcome, higher complication rate, longer fusion and higher operative cost compared to non-severe scoliosis. | Eur Spine J | 2022 | 35066683 | PubTator, text mining | PubMed |
| Wading through Molasses: A qualitative examination of the experiences, perceptions, attitudes, and knowledge of Australian medical practitioners regarding medical billing. | PLoS One | 2022 | 35061797 | PubTator, text mining | PubMed |
| Identification of key gene signatures for the overall survival of ovarian cancer. | J Ovarian Res | 2022 | 35057823 | PubTator, text mining | PubMed |
| Integrity of the Intestinal Barrier: The Involvement of Epithelial Cells and Microbiota-A Mutual Relationship. | Animals (Basel) | 2022 | 35049768 | PubTator, text mining | PubMed |
| Investigating primary healthcare practitioners' barriers and enablers to referral of patients with COPD to pulmonary rehabilitation: a mixed-methods study using the Theoretical Domains Framework. | BMJ Open | 2022 | 35045995 | PubTator, text mining | PubMed |
| Vaccination against Her-2/neu, with focus on peptide-based vaccines. | ESMO Open | 2022 | 35026721 | PubTator, text mining | PubMed |
| A small stem-loop-forming region within the 3'-UTR of a nonpolyadenylated LCMV mRNA promotes translation. | J Biol Chem | 2022 | 35026225 | PubTator, text mining | PubMed |
| Adhesion of Enteropathogenic, Enterotoxigenic, and Commensal Escherichia coli to the Major Zymogen Granule Membrane Glycoprotein 2. | Appl Environ Microbiol | 2022 | 35020452 | PubTator, text mining | PubMed |
| Effect of Solvents on Proline Modified at the Secondary Sphere: A Multivariate Exploration. | J Org Chem | 2022 | 35019660 | PubTator, text mining | PubMed |
| Therapeutic vaccines for breast cancer: Has the time finally come? | Eur J Cancer | 2022 | 34823982 | PubTator, text mining | PubMed |
| Isolation and genomic characterization of a Chinese NADC34-like PRRSV isolated from Jiangsu province. | Transbound Emerg Dis | 2022 | 34786872 | PubTator, text mining | PubMed |
| Recognizing Dysfunctional Innate and Adaptive Immune Responses Contributing to Liver Damage in Patients With Cirrhosis. | J Clin Exp Hepatol | 2022 | 34744379 | PubTator, text mining | PubMed |
| Is it feasible to learn research skills in addition to audit skills through clinical audit? A mixed methods study in general practice. | Ir J Med Sci | 2022 | 34664225 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2813/papers?page=32